University of California at San Francisco (UCSF)

University of California San Francisco

Dr. Beljanski showed that the active compounds in his Pao pereira extract do cross the blood brain barrier and so may exert their anti-tumor effect on brain cancers, including glioblastoma.

The Beljanski Foundation is now sponsoring a new research program focused on providing an improved treatment. The Beljanski Foundation is collaborating with researchers at the University of California at San Francisco (UCSF) to study the effectiveness of a plant extract, Pao pereira, that has been shown to have a broad spectrum of anti-cancer activity. The French scientist Mirko Beljanski, PhD, at the Pasteur Institute in Paris, developed this extract.


Posted in List of Partners.